Search
Search Results
##search.searchResults.foundPlural##
-
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4275PDF: 1474HTML: 1537Untitled: 219 -
The diagnostic pitfalls of mucormycosis
873PDF: 704HTML: 236 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2607PDF: 1065HTML: 100 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1220PDF: 643HTML: 7718 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1019PDF: 955HTML: 313 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1268PDF: 1068PDF: 862HTML: 152 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12307PDF: 1664HTML: 4151Cover letter: 193Figure 1: 199 -
POST-LOAD PLASMA GLUCOSE INCREASE (PG-GAP) AS A RISK FACTOR FOR DEVELOPING DYSGLYCEMIA IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (Β-TDT): RETROSPECTIVE ANALYSIS OVER 8 YEARS Post load plasma glucose increase and the risk of glucose dysregulation in thalassemia
465PDF: 232HTML: 33 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3123PDF: 1568HTML: 252 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1989PDF: 787HTML: 1031 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2726PDF: 1108HTML: 3270 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
605PDF: 211Html: 27 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1348PDF: 1288HTML: 87 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2823PDF: 1425HTML: 3041Cover Letter: 199 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1269PDF: 557Suppl. Files: 341HTML: 134 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1321PDF: 450HTML: 155 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1287PDF: 852HTML: 1027Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 168 -
-
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4743PDF: 1745HTML: 2694Untitled: 207 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1263PDF: 999HTML: 112 -







